The number of US Food and Drug Administration (FDA) class 1 recalls—the most serious classification—for medical devices has been trending upwards. Regulatory News, a publication of the Regulatory Affairs Professional Society (RAPS), reported the news…
A recent analysis of insurance claims data suggests weight-loss medications like Ozempic (semaglutide), Trulicity (dulaglutide), and other glucagon-like peptide-1 (GLP-1) receptor agonists do not increase risks associated with undergoing anesthesia. As reported April 22 in MedPage Today,…
A new guidance document covering the entire process for the selection, labeling, and sterile processing of dilators and ultrasound probes is available from The Association for the Advancement of Medical Instrumentation (AAMI). Released April 17,…